REQUEST A DEMO
Total
USD $0.00
Search more companies

Cellgentek Co., Ltd (South Korea)

Main Activities: Software Publishers
Full name: Cellgentek Co., Ltd Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Company is a Korea-based company mainly engaged in the development and sale of software. The Company is involved in the manufacturing and sale of analysis systems, simulators, software and solutions. The main products consist of solutions for batch control of bio equipments, e-mail management solutions, solutions for management of the reagent records and safety protection under the name of Lab Bio Plus, as well as solutions for pharmaceutical management. The Company was founded on August 02, 2002 and its shares are listed on KOREA NEW EXCHANGE(KONEX) on December 13, 2016.

Headquarters
110-6 Selentech, Osong Life 2, Osong-Eup, Heungdeok-Gu, Cheongju-Si, Chungcheongbuk-Do
Cheongju; Chungcheongbuk;

Contact Details: Purchase the Cellgentek Co., Ltd report to view the information.

Website: http://cellgentek.co.kr

Basic Information
Total Employees:
Purchase the Cellgentek Co., Ltd report to view the information.
Outstanding Shares:
Purchase the Cellgentek Co., Ltd report to view the information.
Financial Auditors:
Purchase the Cellgentek Co., Ltd report to view the information.
Incorporation Date:
2002
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Auditor
Purchase this report to view the information.
Auditor
Purchase this report to view the information.
Auditor
Subsidiaries
주식회사 셀젠텍
Company Performance
Financial values in the chart are available after Cellgentek Co., Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-3.05%
Total operating revenue
1.6%
Operating profit (EBIT)
N/A
EBITDA
-47.98%
Net Profit (Loss) for the Period
N/A
Total assets
28.99%
Total equity
51.68%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-71.97%
Quick Ratio
-1.37%
Cash Ratio
-0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?